Skip to main content

Advertisement

Log in

The hypothalamic–pituitary–gonadal axis and the enigma of Alzheimer disease sex differences

  • Comment
  • Published:

From Nature Reviews Endocrinology

View current issue Sign up to alerts

Alzheimer disease has a sex bias: women are twice as likely as men to be affected. Studies have linked elevated follicle-stimulating hormone (FSH) levels to worsened Alzheimer disease pathology and cognitive decline in mice. Exploring the interaction of FSH with APOE4 has uncovered new aspects of Alzheimer disease. The therapeutic potential of FSH and gonadotropin-releasing hormone have also been highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Unlocking the neuroendocrine key to the Alzheimer disease enigma.

References

  1. Andersen, K. et al. Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. Neurology 53, 1992–1997 (1999).

    Article  CAS  PubMed  Google Scholar 

  2. Irvine, K., Laws, K. R., Gale, T. M. & Kondel, T. K. Greater cognitive deterioration in women than men with Alzheimer’s disease: a meta analysis. J. Clin. Exp. Neuropsychol. 34, 989–998 (2012).

    Article  PubMed  Google Scholar 

  3. Altmann, A., Tian, L., Henderson, V. W. & Greicius, M. D. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann. Neurol. 75, 563–573 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Matyi, J. M., Rattinger, G. B., Schwartz, S., Buhusi, M. & Tschanz, J. T. Lifetime estrogen exposure and cognition in late life: the Cache County Study. Menopause 26, 1366–1374 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Xiong, J. et al. FSH blockade improves cognition in mice with Alzheimer’s disease. Nature 603, 470–476 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Xiong, J. et al. FSH and ApoE4 contribute to Alzheimer’s disease-like pathogenesis via C/EBPβ/δ-secretase in female mice. Nat. Commun. 14, 6577 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Urban, R. J., Veldhuis, J. D., Blizzard, R. M. & Dufau, M. L. Attenuated release of biologically active luteinizing hormone in healthy aging men. J. Clin. Invest. 81, 1020–1029 (1988).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Manfredi-Lozano, M. et al. GnRH replacement rescues cognition in Down syndrome. Science 377, eabq4515 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Wiseman, F. K. et al. A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome. Nat. Rev. Neurosci. 16, 564–574 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Messina, A. et al. A microRNA switch regulates the rise in hypothalamic GnRH production before puberty. Nat. Neurosci. 19, 835–844 (2016).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the support of the European Research Council ERC-Synergy-Grant-2019-WATCH No 810331 and the ERC-2023-POC-UPGRADE No 101123221.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincent Prévot.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sauvé, F., Kacimi, L. & Prévot, V. The hypothalamic–pituitary–gonadal axis and the enigma of Alzheimer disease sex differences. Nat Rev Endocrinol 20, 317–318 (2024). https://doi.org/10.1038/s41574-024-00981-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41574-024-00981-1

  • Springer Nature Limited

Navigation